Volume 12 Issue 5
Sep.  2021
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2021  >  12(5): 506-511
Jiao Guohui, Chen Jingyu. Development and prospect of clinical research on lung transplantation in post-COVID-19 era[J]. ORGAN TRANSPLANTATION, 2021, 12(5): 506-511. doi: 10.3969/j.issn.1674-7445.2021.05.002
Citation: Jiao Guohui, Chen Jingyu. Development and prospect of clinical research on lung transplantation in post-COVID-19 era[J]. ORGAN TRANSPLANTATION, 2021, 12(5): 506-511. doi: 10.3969/j.issn.1674-7445.2021.05.002
shu

Development and prospect of clinical research on lung transplantation in post-COVID-19 era

doi: 10.3969/j.issn.1674-7445.2021.05.002

  • Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi Lung Transplant Center, Jiangsu Lung Transplant Center, Wuxi 214000, China

More Information
  • Corresponding author: Chen Jingyu, E-mail: chenjy@wuxiph.com
  • Received Date: 2021-06-15
    Available Online: 2021-09-15
  • Publish Date: 2021-09-15
    Abstract
  • Lung transplantation has been advanced for nearly half a century around the globe, and it has been developed rapidly for over 20 years in China. The field of lung transplantation in China has been gradually integrated into the international community. The outbreak of novel coronavirus pneumonia (COVID-19) in 2020 brought big challenges, as well as diverted the worldwide attention to the development of lung transplantation in China, accelerating international communication and cooperation. With the steadily deepening of clinical and basic research on lung transplantation for severe cases of COVID-19, organ transplant physicians have deepened the understanding and thinking of the maintenance of donors, selection of elderly and pediatric candidates, and perioperative management of recipients, as the future perspective of lung transplantation in China. For interdisciplinary research related to lung transplantation, it is necessary to carry out multi-center clinical trials with qualified study design and constantly promote the theoretic and practical innovation.

     

    • FullText(HTML)
  • loading
    • References(29)
  • [1]
    CHEN JY, QIAO K, LIU F, et al. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis[J]. Chin Med J (Engl), 2020, 133(12): 1390-1396. DOI: 10.1097/CM9.0000000000000839.
    [2]
    LUO WR, YU H, GOU JZ, et al. Histopathologic findings in the explant lungs of a patient with COVID-19 treated with bilateral orthotopic lung transplant[J]. Transplantation, 2020, 104(11): e329-e331. DOI: 10.1097/TP.0000000000003412.
    [3]
    CHEN XJ, LI K, XU L, et al. Novel insight from the first lung transplant of a COVID-19 patient[J]. Eur J Clin Invest, 2021, 51(1): e13443. DOI: 10.1111/eci.13443.
    [4]
    HAN W, ZHU M, CHEN J, et al. Lung transplantation for elderly patients with end-stage COVID-19 pneumonia[J]. Ann Surg, 2020, 272(1): e33-e34. DOI: 10.1097/SLA. 0000000000003955.
    [5]
    WU B, HUANG M, JIAO G, et al. Lung transplantation during the outbreak of coronavirus disease 2019 in China[J]. J Thorac Cardiovasc Surg, 2020, DOI: 10.1016/j.jtcvs.2020.10.154[Epubahead of print].
    [6]
    WANG Y, YANG H, LIU H, et al. Strategies to halt 2019 novel coronavirus (SARS-CoV-2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China[J]. Am J Transplant, 2020, 20(7): 1837-1839. DOI: 10.1111/ajt.15972.
    [7]
    SUN Q, QIU H, HUANG M, et al. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province[J]. Ann Intensive Care, 2020, 10(1): 33. DOI: 10.1186/s13613-020-00650-2.
    [8]
    HAWKINS RB, MEHAFFEY JH, CHARLES EJ, et al. Lung transplantation for severe post-coronavirus disease 2019 respiratory failure[J]. Transplantation, 2021, 105(6): 1381-1387. DOI: 10.1097/TP.0000000000003706.
    [9]
    XUAN TM, WANG XX, PU XY, et al. Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report[J]. J Zhejiang Univ Sci B, 2020, 21(5): 411-415. DOI: 10.1631/jzus.B2000182.
    [10]
    CHEN J, WU H, YU Y, et al. Pulmonary alveolar regeneration in adult COVID-19 patients[J]. Cell Res, 2020, 30(8): 708-710. DOI: 10.1038/s41422-020-0369-7.
    [11]
    陈英伦, 卫栋, 王梓涛, 等. IL-10改善心脏死亡大鼠离体肺灌注后供肺功能的实验研究[J]. 器官移植, 2021, 12(4): 421-427. DOI: 10.3969/j.issn.1674-7445. 2021.04.008.

    CHEN YL, WEI D, WANG ZT, et al. Experimental study on the role of IL-10 in improving donor lung function after ex vivo lung perfusion in rats of cardiac death[J]. Organ Transplant, 2021, 12(4): 421-427. DOI: 10.3969/j.issn.1674-7445.2021.04.008.
    [12]
    LI XS, HU CX, LIU F, et al. Green channel of human organ transport improved the utilization rate of Chinese citizens' donated lungs: a single-center data analysis[J]. Chin Med J (Engl), 2021, 134(2): 222-224. DOI: 10.1097/CM9.0000000000001325.
    [13]
    HUANG J, TIAN D, CHEN J. A modified lobar transplants combining RUL and RML for small recipients[J]. Ann Thorac Surg, 2021, DOI: 10.1016/j.athoracsur.2021.03.080[Epubahead of print].
    [14]
    YUE B, WU B, ZHANG J, et al. Pediatric lung transplantation in the largest lung transplantation center of China: embarking on a long road[J]. Sci Rep, 2020, 10(1): 12471. DOI: 10.1038/s41598-020-69340-0.
    [15]
    VALAPOUR M, LEHR CJ, SKEANS MA, et al. OPTN/SRTR 2017 annual data report: lung[J]. Am J Transplant, 2019, 19 (Suppl 2): 404-484. DOI: 10.1111/ajt.15279.
    [16]
    COSTELLO JP, CARVAJAL HG, ABARBANELL AM, et al. Surgical considerations in infant lung transplantation: challenges and opportunities[J]. Am J Transplant, 2021, 21(1): 15-20. DOI: 10.1111/ajt.16282.
    [17]
    BLUME ED, VANDERPLUYM C, LORTS A, et al. Second annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: pre-implant characteristics and outcomes[J]. J Heart Lung Transplant, 2018, 37(1): 38-45. DOI: 10.1016/j.healun.2017.06.017.
    [18]
    DE LUCA D, TISSIERES P, KNEYBER MCJ, et al. Lung transplantation in neonates and infants: ESPNIC survey of European neonatologists and pediatric intensivists[J]. Eur J Pediatr, 2021, 180(1): 295-298. DOI: 10.1007/s00431-020-03742-0.
    [19]
    SCHWEIGER T, HOETZENECKER K. Is chronological age still a hard selection criterion for lung transplantation?[J]. J Heart Lung Transplant, 2021, 40(2): 99-100. DOI: 10.1016/j.healun.2020.11.011.
    [20]
    LEHR CJ, BLACKSTONE EH, MCCURRY KR, et al. Extremes of age decrease survival in adults after lung transplant[J]. Chest, 2020, 157(4): 907-915. DOI: 10.1016/j.chest.2019.06.042.
    [21]
    MOSHER CL, WEBER JM, FRANKEL CW, et al. Risk factors for mortality in lung transplant recipients aged ≥65 years: a retrospective cohort study of 5, 815 patients in the Scientific Registry of Transplant Recipients[J]. J Heart Lung Transplant, 2021, 40(1): 42-55. DOI: 10.1016/j.healun.2020.10.009.
    [22]
    PENG G, YANG C, LIU M, et al. Pulmonary fibrosis combined with lung cancer following lung transplantation: should we do more?[J]. Transl Lung Cancer Res, 2021, 10(3): 1588-1593. DOI: 10.21037/tlcr-21-46.
    [23]
    HU CX, CHEN WH, HE JX, et al. Lung transplantation in China between 2015 and 2018[J]. Chin Med J (Engl), 2019, 132(23): 2783-2789. DOI: 10.1097/CM9.00000000 00000543.
    [24]
    COMBS MP, WHEELER DS, LUTH JE, et al. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study[J]. Lancet Respir Med, 2021, 9(6): 601-612. DOI: 10.1016/S2213-2600(20)30405-7.
    [25]
    GRASSELLI G, SCARAVILLI V, ALAGNA L, et al. Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome[J]. Ann Intensive Care, 2019, 9(1): 141. DOI: 10.1186/s13613-019-0615-7.
    [26]
    TIAN D, SHⅡYA H, SATO M, et al. Rat lung transplantation model: modifications of the cuff technique[J]. Ann Transl Med, 2020, 8(6): 407. DOI: 10.21037/atm.2020.02.46.
    [27]
    WU H, YU Y, HUANG H, et al. Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells[J]. Cell, 2020, 180(1): 107-121. DOI: 10.1016/j.cell.2019.11.027.
    [28]
    YUAN Q, BASIT A, LIANG W, et al. Pazopanib ameliorates acute lung injuries via inhibition of MAP3K2 and MAP3K3[J]. Sci Transl Med, 2021, 13(591): eabc2499. DOI: 10.1126/scitranslmed.abc2499.
    [29]
    SWOL J, SHIGEMURA N, ICHIBA S, et al. Artificial lungs--where are we going with the lung replacement therapy?[J]. Artif Organs, 2020, 44(11): 1135-1149. DOI: 10.1111/aor.13801.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (733) PDF downloads(124) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return